HGF and Myocardial fibrosis: Our data suggested that transfection of HGF into BMSCs for MI treatment could significantly improve LV function, stimulate microvessel angiogenesis, enhance cardiomyocyte regeneration, and inhibit myocardial fibrosis compared with BMSCs or HGF injection alone.